Location: New York, NY
CIK: 0001009258 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 13, 2017
Total Value: $2.22B (82.4% shares, 17.6% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AVEXIS INC | 1,547,386 | $150M | 6.7% | — | — | COM | 05366U100 |
| MCK | MCKESSON CORP | 729,000 | $112M | 5.0% | — | — | COM | 58155Q103 |
| — | MYLAN N V | 3,153,611 | $98.93M | 4.5% | — | — | SHS EURO | N59465109 |
| — | HORIZON PHARMA PLC | 6,917,070 | $87.71M | 4.0% | — | — | SHS | G4617B105 |
| GKOS | GLAUKOS CORP | 2,527,032 | $83.39M | 3.8% | — | — | COM | 377322102 |
| — | MALLINCKRODT PUB LTD CO | 1,860,137 | $69.51M | 3.1% | — | — | SHS | G5785G107 |
| DXCM | DEXCOM INC | 1,419,911 | $69.47M | 3.1% | — | — | COM | 252131107 |
| — | HORIZON PHARMA INVT LTD | 74,100,000 | $66.89M | 3.0% | — | — | NOTE 2.500% 3/1 | 44052TAB7 |
| — | MYOKARDIA INC | 1,365,039 | $58.49M | 2.6% | — | — | COM | 62857M105 |
| — | ISIS PHARMACEUTICALS INC DEL | 45,700,000 | $48.5M | 2.2% | — | — | NOTE 1.000%11/1 | 464337AJ3 |
| — | KEMPHARM INC | 75,000,000 | $45.69M | 2.1% | — | — | NOTE 5.500% 2/0 | 488445AB3 |
| — | NXSTAGE MEDICAL INC | 1,579,285 | $43.59M | 2.0% | — | — | COM | 67072V103 |
| — | AUDENTES THERAPEUTICS INC | 1,525,410 | $42.73M | 1.9% | — | — | COM | 05070R104 |
| EDIT | EDITAS MEDICINE INC | 1,709,400 | $41.04M | 1.8% | — | — | COM | 28106W103 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,577,927 | $40.73M | 1.8% | — | — | COM | 00461U105 |
| — | INTERCEPT PHARMACEUTICALS IN | 51,000,000 | $39.67M | 1.8% | — | — | NOTE 3.250% 7/0 | 45845PAA6 |
| — | AVADEL PHARMACEUTICALS PLC | 3,655,494 | $38.38M | 1.7% | — | — | SPONSORED ADR | 05337M104 |
| — | TRINITY BIOTECH INVT LTD | 48,000,000 | $38.19M | 1.7% | — | — | NOTE 4.000% 4/0 | 89643QAB4 |
| — | INTERSECT ENT INC | 1,210,000 | $37.69M | 1.7% | — | — | COM | 46071F103 |
| — | GW PHARMACEUTICALS PLC | 362,724 | $36.81M | 1.7% | — | — | ADS | 36197T103 |
| — | ENDOLOGIX INC | 40,500,000 | $35.03M | 1.6% | — | — | NOTE 3.250%11/0 | 29266SAB2 |
| — | NEVRO CORP | 27,600,000 | $32.76M | 1.5% | — | — | NOTE 1.750% 6/0 | 64157FAA1 |
| ASND | ASCENDIS PHARMA A S | 850,000 | $30.81M | 1.4% | — | — | SPONSORED ADR | 04351P101 |
| — | AERIE PHARMACEUTICALS INC | 632,686 | $30.75M | 1.4% | — | — | COM | 00771V108 |
| ANAB | ANAPTYSBIO INC | 824,338 | $28.81M | 1.3% | — | — | COM | 032724106 |
| NTRA | NATERA INC | 2,181,542 | $28.12M | 1.3% | — | — | COM | 632307104 |
| — | DBV TECHNOLOGIES S A | 655,897 | $27.84M | 1.3% | — | — | SPONSORED ADR | 23306J101 |
| PODD | INSULET CORP | 497,000 | $27.38M | 1.2% | — | — | COM | 45784P101 |
| — | ARENA PHARMACEUTICALS INC | 1,072,329 | $27.34M | 1.2% | — | — | COM NEW | 040047607 |
| — | LANNET INC | 1,453,259 | $26.81M | 1.2% | — | — | COM | 516012101 |
| BCRX | BIOCRYST PHARMACEUTICALS | 4,975,451 | $26.07M | 1.2% | — | — | COM | 09058V103 |
| — | K2M GROUP HLDGS INC | 20,000,000 | $24.5M | 1.1% | — | — | NOTE 4.125% 8/1 | 48273JAB3 |
| — | ACCELERON PHARMA INC | 615,000 | $22.95M | 1.0% | — | — | COM | 00434H108 |
| SEM | SELECT MED HLDGS CORP | 1,194,609 | $22.94M | 1.0% | — | — | COM | 81619Q105 |
| — | PATTERSON COMPANIES INC | 566,000 | $21.88M | 1.0% | — | — | COM | 703395103 |
| — | FLUIDIGM CORP DEL | 27,715,000 | $20.26M | 0.9% | — | — | NOTE 2.750% 2/0 | 34385PAA6 |
| — | SYROS PHARMACEUTICALS INC | 1,268,945 | $18.68M | 0.8% | — | — | COM | 87184Q107 |
| MOH | MOLINA HEALTHCARE INC | 258,000 | $17.74M | 0.8% | — | — | COM | 60855R100 |
| — | SELECTA BIOSCIENCES INC | 951,629 | $17.37M | 0.8% | — | — | COM | 816212104 |
| — | AAC HLDGS INC | 1,733,276 | $17.21M | 0.8% | — | — | COM | 000307108 |
| — | RECRO PHARMA INC | 1,901,685 | $17.08M | 0.8% | — | — | COM | 75629F109 |
| — | SYNLOGIC INC | 850,143 | $16.16M | 0.7% | — | — | COM | 87166L100 |
| — | PORTOLA PHARMACEUTICALS INC | 298,545 | $16.13M | 0.7% | — | — | COM | 737010108 |
| EHTH | EHEALTH INC | 672,994 | $16.08M | 0.7% | — | — | COM | 28238P109 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 945,710 | $15.89M | 0.7% | — | — | ORD SHS | G6855A103 |
| — | AMAG PHARMACEUTICALS INC | 16,250,000 | $15.75M | 0.7% | — | — | NOTE 3.250% 6/0 | 00163UAD8 |
| — | LOXO ONCOLOGY INC | 169,000 | $15.57M | 0.7% | — | — | COM | 548862101 |
| ARDX | ARDELYX INC | 2,746,480 | $15.38M | 0.7% | — | — | COM | 039697107 |
| — | ADVANCED ACCELERATOR APPLIC | 218,000 | $14.74M | 0.7% | — | — | SPONSORED ADS | 00790T100 |
| — | NEOS THERAPEUTICS INC | 1,568,921 | $14.36M | 0.6% | — | — | COM | 64052L106 |
| — | BLUEPRINT MEDICINES CORP | 203,000 | $14.14M | 0.6% | — | — | COM | 09627Y109 |
| AGIO | AGIOS PHARMACEUTICALS INC | 208,000 | $13.88M | 0.6% | — | — | COM | 00847X104 |
| CTMX | CYTOMX THERAPEUTICS INC | 756,822 | $13.75M | 0.6% | — | — | COM | 23284F105 |
| — | AEGERION PHARMACEUTICALS INC | 16,600,000 | $13.36M | 0.6% | — | — | NOTE 2.000% 8/1 | 00767EAB8 |
| — | EPIZYME INC | 700,526 | $13.35M | 0.6% | — | — | COM | 29428V104 |
| GLPG | GALAPAGOS NV | 130,000 | $13.23M | 0.6% | — | — | SPON ADR | 36315X101 |
| WVE | WAVE LIFE SCIENCES LTD | 580,000 | $12.62M | 0.6% | — | — | SHS | Y95308105 |
| XNCR | XENCOR INC | 522,000 | $11.96M | 0.5% | — | — | COM | 98401F105 |
| ARGX | ARGENX SE | 509,022 | $11.51M | 0.5% | — | — | SPONSORED ADR | 04016X101 |
| — | ALPINE IMMUNE SCIENCES INC | 933,100 | $10.82M | 0.5% | — | — | COM | 02083G100 |
| — | INVUITY INC | 1,177,229 | $10.48M | 0.5% | — | — | COM NEW | 46187J205 |
| — | ALLSCRIPTS HEALTHCARE SOLUTN | 9,671,000 | $10.3M | 0.5% | — | — | NOTE 1.250% 7/0 | 01988PAD0 |
| CNC | CENTENE CORP DEL | 102,000 | $9.871M | 0.4% | — | — | COM | 15135B101 |
| SGMO | SANGAMO THERAPEUTICS INC | 653,000 | $9.795M | 0.4% | — | — | COM | 800677106 |
| — | INVITAE CORP | 900,000 | $8.433M | 0.4% | — | — | COM | 46185L103 |
| — | ALIMERA SCIENCES INC | 6,052,935 | $8.171M | 0.4% | — | — | COM | 016259103 |
| — | IMMUNOMEDICS INC | 582,000 | $8.136M | 0.4% | — | — | COM | 452907108 |
| — | MARINUS PHARMACEUTICALS INC | 1,355,000 | $7.954M | 0.4% | — | — | COM | 56854Q101 |
| — | CLEMENTIA PHARMACEUTICALS IN | 462,387 | $7.81M | 0.4% | — | — | COM | 185575107 |
| — | NUCANA PLC | 424,950 | $7.806M | 0.4% | — | — | SPONSORED ADR | 67022C106 |
| — | AXOVANT SCIENCES LTD | 1,052,000 | $7.238M | 0.3% | — | — | COM | G0750W104 |
| AXGN | AXOGEN INC | 344,428 | $6.665M | 0.3% | — | — | COM | 05463X106 |
| MCK | MCKESSON CORP | 43,200 | $6.636M | 0.3% | — | — | Call | 58155Q103 |
| — | MYOVANT SCIENCES LTD | 400,685 | $6.199M | 0.3% | — | — | COM | G637AM102 |
| — | DECIPHERA PHARMACEUTICALS IN | 325,000 | $6.172M | 0.3% | — | — | COM | 24344T101 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 165,000 | $6.168M | 0.3% | — | — | COM | G11196105 |
| — | REATA PHARMACEUTICALS INC | 190,000 | $5.909M | 0.3% | — | — | CL A | 75615P103 |
| — | AGILE THERAPEUTICS INC | 1,221,775 | $5.449M | 0.2% | — | — | COM | 00847L100 |
| — | STEADYMED LTD | 1,418,787 | $4.753M | 0.2% | — | — | SHS | M84920103 |
| — | FOAMIX PHARMACEUTICALS LTD | 817,435 | $4.537M | 0.2% | — | — | SHS | M46135105 |
| — | SIERRA ONCOLOGY INC | 2,800,000 | $4.34M | 0.2% | — | — | COM | 82640U107 |
| — | SAGE THERAPEUTICS INC | 68,000 | $4.236M | 0.2% | — | — | COM | 78667J108 |
| — | ARALEZ PHARMACEUTICALS INC | 1,644,583 | $3.766M | 0.2% | — | — | COM | 03852X100 |
| — | OBALON THERAPEUTICS INC | 351,284 | $3.348M | 0.2% | — | — | COM | 67424L100 |
| — | BIOSCRIP INC | 1,107,166 | $3.045M | 0.1% | — | — | COM | 09069N108 |
| — | AKARI THERAPEUTICS PLC | 433,551 | $2.662M | 0.1% | — | — | SPONSORED ADR | 00972G108 |
| — | PROTEON THERAPEUTICS INC | 1,224,899 | $2.45M | 0.1% | — | — | COM | 74371L109 |
| VYGR | VOYAGER THERAPEUTICS INC | 117,647 | $2.422M | 0.1% | — | — | COM | 92915B106 |
| — | INTRA CELLULAR THERAPIES INC | 118,116 | $1.864M | 0.1% | — | — | COM | 46116X101 |
| MDXG | MIMEDX GROUP INC | 150,000 | $1.782M | 0.1% | — | — | COM | 602496101 |
| — | RA PHARMACEUTICALS INC | 102,150 | $1.491M | 0.1% | — | — | COM | 74933V108 |